Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Hodgkin's lymphoma Stories

2013-11-07 08:33:43

- ASH Presentations Highlight Pre-Clinical Data Demonstrating Combination Treatment Synergies for EPZ-5676 and EPZ-6438 Clinical Programs and MLL-PTD Expansion Indication Opportunity - CAMBRIDGE, Mass., Nov. 7, 2013 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, will present pre-clinical data on EPZ-5676 and EPZ-6438, the Company's DOT1L and EZH2 clinical...

2013-10-31 08:32:19

Management will discuss pivotal trial plans for its drug candidate Iomab(TM)-B and its potential as a new treatment paradigm for certain blood cancers NEW YORK, Oct. 31, 2013 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, will host a general corporate update and Virtual Roadshow to discuss the current plans...

2013-10-28 08:30:29

Approval of Premium-Priced Novel Agents, Coupled With Rituximab's Continued Dominance, Will Drive a Robust Annual Growth, According to a New Report from Decision Resources BURLINGTON, Mass., Oct. 28, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, from 2012 to 2022, the launch of five premium-priced new agents--Johnson & Johnson/Janssen/Pharmacyclics' ibrutinib, Gilead Sciences'...

2013-10-16 08:29:04

The Leukemia & Lymphoma Society's School Fundraising Campaign Helps Fund Cures WHITE PLAINS, N.Y., Oct. 16, 2013 /PRNewswire/ -- "High School students can have an impact in the fight against blood cancers," states George Omiros, executive vice president, chief campaign and field development officer, The Leukemia & Lymphoma Society (LLS), the world's largest non-profit dedicated to blood cancer cures. "Last year alone, more than 4,000 high schools, along with 25,000 participating middle...

2013-10-15 04:21:01

SEATTLE, Oct. 15, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that the National Institute for Health and Care Excellence (NICE), a non-departmental public body of the Department of Health in the United Kingdom (UK), issued second draft guidance on PIXUVRI(®) (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (aggressive B-cell NHL). NICE's...

2013-10-09 12:23:55

Hosted by San Francisco Yacht Club October 19-20 SAN FRANCISCO, Oct. 9, 2013 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) is pleased to announce that Olympic gold medalist and America's Cup winner, Sir Ben Ainslie, and National Leukemia Cup Regatta Chairman, Gary Jobson, will be attending the eighth annual Leukemia Cup Regatta on October 19-20, 2013 at The San Francisco Yacht Club (SFYC) in Belvedere, Calif. The Leukemia Cup Regatta supports LLS's mission to...

2013-10-02 12:30:02

WHITE PLAINS, N.Y., Oct. 2, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) today announced the appointment of Lee Greenberger, Ph.D., an executive with a significant oncology research and development background, as its new chief scientific officer. http://photos.prnewswire.com/prnvar/20131002/MM90861 In this role, Dr. Greenberger will be responsible for planning and executing the strategy for all LLS research programs, including grant funding programs, the Therapy...

2013-09-27 12:24:53

John Trainor and Steve Michaels are members of The Leukemia & Lymphoma Society's Team In Training ATLANTA, Sept. 27, 2013 /PRNewswire/ -- John Trainor, CIO at Aaron's, Inc. (NYSE: AAN) and Steven A. Michaels, VP of Finance at Aaron's, Inc. are training for the Intermedix Ironman 70.3 Augusta on Sunday, September 29(th) with The Leukemia & Lymphoma Society's Team In Training (TNT). Both executives are part of a team of 50 triathletes who are preparing to tackle the distance of a...

2013-09-26 12:30:02

John Theurer Cancer Center Chairman and Lymphoma Chief Andre Goy, M.D., M.S., Continues to Lead Advances in MCL Research and Treatment HACKENSACK, N.J., Sept. 26, 2013 /PRNewswire/ -- Andre Goy, M.D., M.S., Chairman and Director of John Theurer Cancer Center and Chief of the Lymphoma Program, has just published two important papers in relapsed/refractory mantle-cell lymphoma (MCL) in the Journal of Clinical Oncology and New England Journal of Medicine. MCL is a difficult subtype...

2013-09-24 08:30:46

Quiznos Launches National Campaign During Blood Cancer Awareness Month DENVER, Sept. 24, 2013 /PRNewswire/ -- Today, Quiznos announced that participating restaurants across the U.S. and Canada are partnering with The Leukemia & Lymphoma Society (LLS) in an effort to end cancer forever. This September and October, customers are encouraged to donate $1 or $5 with their order to help fund cancer research and save lives in the communities where Quiznos does business. "The research...